Article

Justine Smith begins term as new ARVO president

Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology.

Rockville, MD-Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology (ARVO).

Dr. Smith succeeds Peng T. Khaw, MD, PhD, FARVO, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in England, whose 1-year term ended following the ARVO annual meeting earlier this month.

“It’s an honor to serve as president of this international group of leading and emerging leaders in eye and vision research,” Dr. Smith said. “I look forward to collaborating with our members in the coming year as we explore our efforts advancing areas as diverse as neuroscience, tissue imaging, and preventative medicine under the ARVO 2014 theme, ‘Leading Eye and Vision Research.’”

ARVO also announced its new vice presidents. They are John S. Penn, PhD, FARVO, of Vanderbilt University and David R. Williams, PhD, FARVO, of the University of Rochester.

William F. Mieler, MD, of the University of Illinois-Chicago is president-elect amd will serve the 2014-2015 term. Carol B. Toris, PhD, FARVO, of the University of Rochester is the vice president-elect for that term.

In addition, ARVO members elected two new trustees to its board. Serving a 5-year term are Sarah E. Coupland, MBBS, PhD, of the University of Liverpool, representing the Anatomy Pathology Section, and Claude F. Burgoyne, MD, FARVO, of the Devers Eye Institute/Legacy Research Institute, representing the Glaucoma Section. The new trustees began their terms after the 2013 annual meeting.

For more articles in this issue of Ophthalmology Times eReport, click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.